Quick Answer
Cellectar Biosciences, Inc. reported Total Assets of $14.98 million for fiscal year 2025.
Cellectar Biosciences, Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $14.98M | -41.2% |
| 2024 | $25.47M | +111.0% |
| 2023 | $12.08M | -44.1% |
| 2022 | $21.59M | -42.0% |
| 2021 | $37.20M | -36.6% |
| 2020 | $58.66M | +378.8% |
| 2019 | $12.25M | -18.6% |
| 2018 | $15.05M | +17.0% |
| 2017 | $12.87M | -16.0% |
| 2016 | $15.32M | +101.7% |
| 2015 | $7.60M | -43.4% |
| 2014 | $13.42M | +96.9% |
| 2013 | $6.82M | -40.6% |
| 2012 | $11.48M | +8.7% |
| 2011 | $10.56M | +120.0% |
| 2010 | $4.80M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $14.63M | -60.8% | +6.8% |
| June 30, 2025 | $13.70M | -53.4% | -14.6% |
| March 31, 2025 | $16.04M | -62.6% | -37.0% |
| December 31, 2024 | $25.47M | +111.0% | -31.7% |
| September 30, 2024 | $37.29M | +73.0% | +26.9% |
| June 30, 2024 | $29.38M | +351.4% | -31.5% |
| March 31, 2024 | $42.91M | +189.2% | +255.3% |
| December 31, 2023 | $12.08M | -44.1% | -44.0% |
- Cellectar Biosciences, Inc. showed a decrease of -41.2% in Total Assets compared to the prior fiscal year.
- Over the 2010–2025 period, Cellectar Biosciences, Inc.’s total assets has grown by 211.9% (from $4.80 million to $14.98 million).
- The most recent figure is from Cellectar Biosciences, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 4, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: